Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 13.02
-0.68 (-4.96%)
Sep 11, 2026, 5:36 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €651.32 million as of September 11, 2026. Its market cap has increased by 269.70% in one year.
Market Cap
651.32M
Enterprise Value
700.91M
Revenue
70.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.02
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 651.32M, an increase of 345.90%. That is a compound annual growth rate of 7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 651.32M | 148.43% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.58B |
| Inventiva | 897.86M |
| MedinCell | 790.77M |
| DBV Technologies | 697.77M |
| Valneva SE | 549.60M |
| Valerio Therapeutics Société anonyme | 359.60M |
| Transgene | 241.29M |
| Cellectis | 199.19M |